BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 20, 2017
View Archived Issues
DelSiTech and C-TRI to jointly develop long-acting controlled release formulations
Read More
Bioharmony Therapeutics receives support to develop lysins for bacterial infections
Read More
BeiGene begins phase II study of pamiparib
Read More
Twin epigenetic study reveals idiopathic epilepsy biomarkers
Read More
Array BioPharma and Pfizer to jointly test several cancer drug combinations
Read More
Shire reports topline results from phase II/III study of SHP-609
Read More
Pilot clinical study of Aclaris Therapeutics' ATI-50002 in vitiligo begins
Read More
REGENXBIO's IND for study of RGX-121 in MPS II now active
Read More
Elacestrant significantly reduced FES uptake in patients with ER+/HER2- breast cancer
Read More
Bispecific antibody targeting [90Y]-DOTA and CD45 may enhance radiotherapy for leukemia
Read More
Critical Outcome Technologies' COTI-2 safe, well tolerated in phase I study
Read More
FDA gives fast track designation to Ovid Therapeutics' OV-101 for Angelman syndrome
Read More
Novel P2X3 and/or P2X2/3 receptor antagonists identified at Shionogi
Read More
First patient screened in Minerva Neurosciences' phase III study of MIN-101
Read More
GlycoMimetics patents novel E-selectin binding inhibitors
Read More
BioMarin initiates first phase III study of valoctocogene roxaparvovec for severe hemophilia A
Read More
Transcriptx presents nucleic acids encodingdynein intermediate chain 1, axonemal
Read More
Updated phase II data for tetrathiomolybdate in patients with breast cancer at risk for recurrence
Read More
FDA approves Luxturna gene therapy for biallelic RPE65 mutation-associated retinal dystrophy
Read More
Faron Pharmaceuticals cleared to continue INFORAAA study of Traumakine
Read More
FDA approves Cabometyx for previously untreated advanced RCC
Read More
Second Genome's lead candidate demonstrates safety, tolerability in phase I study
Read More
Solid Biosciences initiates phase I/II study of SGT-001 in Duchenne muscular dystrophy
Read More
Otsuka and X-Chem sign collaborative research agreement
Read More
Onconova and HanX enter license and collaborative development agreement for ON-123300
Read More
FDA approves Prexxartan
Read More
Promising results for novel anti-EGFR radiotracer in patients with non-small cell lung cancer
Read More
FDA accepts for review BLA for Samsung Bioepis' trastuzumab biosimilar
Read More
FDA approves Bosulif for newly diagnosed Ph+ CML
Read More
Biogen and Ionis enter new collaboration for SMA
Read More